Professional & Consulting
Opportunity timeline
PostedSep 2, 2026
DeadlineOct 2, 2026
In plain English
The National Institutes of Health seeks research on whole-person responses, outcomes, and resilience after transformative therapies for people with sickle cell disease. The work is part of the WARRIOR-SCD effort; no quantity, location, eligibility, or dates are provided.
About this opportunity
Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD)
Time remaining
Closes Oct 2, 2026
18Days
:13Hours
:42Min
:50Sec
Related Opportunities
Illumina DRAGEN Tier 3 Throughput License and v4 Server
National Institutes of HealthRFP Bethesda, MD Closing today
Emergent Drug Panel-Version 2 (EDP-V2) Kit
Centers for Disease Control and PreventionRFI Atlanta, GA Closing today
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
National Institutes of HealthRFI Closing today
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
National Institutes of HealthRFI Closing today
Health Advisory Committees Research and Support
Defense Health Agency (dha)RFI Closing today
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-4A17F5